Instructions de recherche:
* Filter the ENTIRE resource library: Choose a OR a to sort all resources.
* Choose Search Items : to filter one collection or perform complex queries.
* Choose Browse by Topic to search by one or more Topics.
Parcourir les contenus (92 total)
-
Créateur: WHO
Sujet: Infection Control
Type d'élément: Guide
Date de la dernière mise à jour: 2019-04-12
Description: The World Health Organization (WHO) is supporting the acceleration of new Ebola interventions in Africa, in particular the development of additional candidate vaccines. This site provides data reviewed by the WHO on the suitability of candidate… -
Créateur: Fallah MP, Skrip LA.
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2019-01-24
Description: This article reviews the testing of Ebola therapies during the outbreak. -
Créateur: CDC
Sujet: Personnel Management
Type d'élément: Guide
Date de la dernière mise à jour: 2019-04-16
Description: Recommendations for organizations sending US-based health care or emergency response workers to areas with Ebola outbreaks and predeparture assessment of any workers traveling from Ebola outbreak areas to the United States. -
Créateur: Daniel, William, Marc Nivet, John Warner, and Daniel K. Podolsky.
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2021-05-20
Description: Emergency use authorizations for two messenger RNA (mRNA) vaccines — the BNT162b2 vaccine (Pfizer–BioNTech) and the mRNA-1273 vaccine (Moderna) — marked important milestones in efforts to respond to the coronavirus disease 2019 (Covid-19) pandemic.…Example only: NETEC provides this item for reference purposes but does not endorse its content. Newer versions may be in place at the providing institution.
-
Créateur: Lurie, Nicole, Melanie Saville, Richard Hatchett, and Jane Halton.
Sujet: Laboratory
Type d'élément: Publication
Date de la dernière mise à jour: 2020-03-30
Description: The need to rapidly develop a vaccine against SARS-CoV-2 comes at a time of explosion in basic scientific understanding, including in areas such as genomics and structural biology, that is supporting a new era in vaccine development. -
Créateur: Ellebedy, A. H., K. J. Jackson, H. T. Kissick, H. I. Nakaya, C. W. Davis, K. M. Roskin, A. K. McElroy, C. M. Oshansky, R. Elbein, S. Thomas, G. M. Lyon, C. F. Spiropoulou, A. K. Mehta, P. G. Thomas, S. D. Boyd, and R. Ahmed
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2016-10
Description: Antigen-specific B cells bifurcate into antibody-secreting cells (ASCs) and memory B cells (MBCs) after infection or vaccination. -
Créateur: Dean, Natalie E., Pierre-Stéphane Gsell, Ron Brookmeyer, Forrest W. Crawford, Christl A. Donnelly, Susan S. Ellenberg, Thomas R. Fleming, M. Elizabeth Halloran, Peter Horby, Thomas Jaki, Philip R. Krause, Ira M. Longini, Sabue Mulangu, Jean-Jacques…
Sujet: Emergency Management
Type d'élément: Publication
Date de la dernière mise à jour: 2020-04-02
Description: Conducting trials of novel interventions during infectious disease emergencies, such as the ongoing Covid-19 pandemic, is increasingly recognized as important for determining the efficacy of potential vaccines and therapies. -
Créateur: The Medical Letter on Drugs and Therapeutics
Sujet: Treatment & Care
Type d'élément: Publication
Date de la dernière mise à jour: 2021-07-15
Description: COVID-19 Vaccine Comparison Chart (online only) effectiveness by vaccine and by variant. -
Créateur: Nelson, Roxanne.
Sujet: Emergency Management
Type d'élément: Publication
Date de la dernière mise à jour: 2020-04-17
Description: The impact of the ongoing pandemic of coronavirus 2019 on immunisation campaigns in low- and middle-income countries is concerning. Roxanne Nelson reports. -
Créateur: University of Minnesota, Center for Infectious Disease Research and Policy
Sujet: Treatment & Care
Type d'élément: Publication
Date de la dernière mise à jour: 2017-01-17
Description: In the third major report from the Wellcome Trust–CIDRAP Ebola Vaccine Team B reflects on progress to date and the remaining challenges faced.